TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7946230

Group type: EXPERIMENTAL
Intervention: Music therapy (one-month course including passive listening and active singing)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Standard medication (control group)
Number of subjects: 76
Study: 3283830

Group type: EXPERIMENTAL
Intervention: Nonionic contrast media (iohexol)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Ionic contrast media (metrizoate)
Number of subjects: 1000
Study: 29259050

Group type: EXPERIMENTAL
Intervention: LBEC0101
Number of subjects: 374

Group type: COMPARATOR
Intervention: ETN-RP
Number of subjects: 374
Study: 28786335

Group type: EXPERIMENTAL
Intervention: Electronic visual analogue scales (eVAS) for pain, fatigue, anxiety, and quality of life
Number of subjects: 104
Study: 26246225

Group type: EXPERIMENTAL
Intervention: BFHI steps 1-9
Number of subjects: 975

Group type: EXPERIMENTAL
Intervention: BFHI steps 1-10
Number of subjects: 975

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 975
Study: 23313462

Group type: EXPERIMENTAL
Intervention: Second-generation antipsychotics
Number of subjects: 227

Group type: COMPARATOR
Intervention: First-generation antipsychotics
Number of subjects: 227
Study: 20839703

Group type: EXPERIMENTAL
Intervention: Resorbable subcuticular staples
Number of subjects: 60

Group type: COMPARATOR
Intervention: Stainless steel staples
Number of subjects: 60
Study: 18608832

Group type: EXPERIMENTAL
Intervention: Novel pedals
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional pedals
Number of subjects: 22
Study: 16398780

Group type: EXPERIMENTAL
Intervention: Monofilament suture material (Biosyn)
Number of subjects: 1139

Group type: COMPARATOR
Intervention: Multifilament suture (Dexon II)
Number of subjects: 1139
Study: 14671147

Group type: EXPERIMENTAL
Intervention: Cinacalcet (30, 40, or 50 mg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 10994619

Group type: EXPERIMENTAL
Intervention: 250-kcal meal
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 550-kcal meal
Number of subjects: 10
Study: 8788290

Group type: EXPERIMENTAL
Intervention: Pancreatic supplementation therapy
Number of subjects: 16

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 16
Study: 1289369

Group type: EXPERIMENTAL
Intervention: Selective decontamination of the digestive tract (SDD) with topical polymyxin, amphotericin B, and tobramycin throughout ITU stay, and intravenous ceftazidime for the first 3 days only.
Number of subjects: 265

Group type: COMPARATOR
Intervention: Contemporaneous control (CC)
Number of subjects: 265

Group type: COMPARATOR
Intervention: Historical control (HC)
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: SDD and CC groups
Number of subjects: 265
Study: 4081704

Group type: EXPERIMENTAL
Intervention: HDCV vaccine
Number of subjects: 120

Group type: COMPARATOR
Intervention: M‐M‐RR II vaccine
Number of subjects: 120
Study: 30701555

Group type: EXPERIMENTAL
Intervention: Randomization tests
Number of subjects: 0

Group type: COMPARATOR
Intervention: Parametric statistics
Number of subjects: 0
Study: 30376687

Group type: EXPERIMENTAL
Intervention: Combined hormone therapy with estrogen and progestin
Number of subjects: 27447

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27447

Group type: EXPERIMENTAL
Intervention: Estrogen therapy alone
Number of subjects: 27447
Study: 27220529

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) with infrared laser to two forehead sites while seated (total 8 min, 1064 nm continuous wave, 250 mW/cm(2), 60 J/cm(2) per site of 13.6 cm(2))
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Acute exercise (EX) of high‐intensity (total 20 min, with 10‐min treadmill running at 85‐90 % VO2max)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined treatment (LLLT + EX)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham control (CON)
Number of subjects: 60
Study: 24580983

Group type: EXPERIMENTAL
Intervention: NAP SACC intervention (educational workshops and consultation visits)
Number of subjects: 552
Study: 22762718

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 231

Group type: COMPARATOR
Intervention: Other causes of death (HF, other cardiovascular causes, noncardiovascular causes)
Number of subjects: 231
Study: 20236907

Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide with halogen light irradiation
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide with LED/diode laser irradiation
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide without irradiation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 10
Study: 17430315

Group type: EXPERIMENTAL
Intervention: Intermittent hemodiafiltration (HDF)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Forced alkaline diuresis
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Combined HDF and forced alkaline diuresis
Number of subjects: 16
Study: 15959371

Group type: EXPERIMENTAL
Intervention: Single percutaneous electrodes
Number of subjects: 20

Group type: COMPARATOR
Intervention: Dual 7-mm percutaneous electrodes
Number of subjects: 20

Group type: COMPARATOR
Intervention: Dual 10-mm percutaneous electrodes
Number of subjects: 20

Group type: COMPARATOR
Intervention: Dual electrodes (both 7-mm and 10-mm)
Number of subjects: 20
Study: 12239258

Group type: EXPERIMENTAL
Intervention: Hemofiltration
Number of subjects: 70

Group type: COMPARATOR
Intervention: Peritoneal dialysis
Number of subjects: 70
Study: 10355234

Group type: EXPERIMENTAL
Intervention: Pure semantic violation condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined semantic and syntactic violation condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phrase structure violation conditions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both semantic violation conditions
Number of subjects: 0
Study: 8594267

Group type: EXPERIMENTAL
Intervention: Oral beta carotene, 50 mg per day for a median of 4.3 years
Number of subjects: 1720

Group type: EXPERIMENTAL
Intervention: Initial plasma beta carotene concentrations in the highest quartile (>0.52 micromol/L)
Number of subjects: 1720
Study: 2020314

Group type: EXPERIMENTAL
Intervention: GM-CSF (1.5, 3, and 6 micrograms/kg/day)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: GM-CSF (3 and 6 micrograms/kg/day)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: GM-CSF (6 micrograms/kg/day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: GM-CSF
Number of subjects: 15
Study: 7044526

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 75

Group type: COMPARATOR
Intervention: Aminoglutethimide-hydrocortisone
Number of subjects: 75
Study: 30175628

Group type: EXPERIMENTAL
Intervention: Fab antivenom (FabAV)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 29522571

Group type: EXPERIMENTAL
Intervention: Postural sensorimotor training (SMT)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham exercise (sub-effective low-intensity training)
Number of subjects: 22
Study: 26939875

Group type: EXPERIMENTAL
Intervention: CR/IDC+ Gleason score ≥7 (n=189)
Number of subjects: 1031

Group type: EXPERIMENTAL
Intervention: CR/IDC- Gleason score ≥7 (n=356)
Number of subjects: 1031

Group type: EXPERIMENTAL
Intervention: Gleason score 6 (n=486)
Number of subjects: 1031

Group type: COMPARATOR
Intervention: CR/IDC- Gleason score 3+4=7
Number of subjects: 1031

Group type: EXPERIMENTAL
Intervention: CR/IDC+ Gleason score 3+4=7
Number of subjects: 1031

Group type: EXPERIMENTAL
Intervention: CR/IDC+ status
Number of subjects: 1031
Study: 25045434

Group type: EXPERIMENTAL
Intervention: Metformin plus Megestrol Acetate (MA) - 160 mg of MA daily plus 0.5 g of metformin thrice daily
Number of subjects: 16

Group type: COMPARATOR
Intervention: Megestrol Acetate (MA) alone - 160 mg of MA daily
Number of subjects: 16
Study: 22461535

Group type: EXPERIMENTAL
Intervention: Sevelamer carbonate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Calcium carbonate
Number of subjects: 0
Study: 19414708

Group type: EXPERIMENTAL
Intervention: Identification of novel genetic polymorphisms in the BDNF gene
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Association analyses of patients with MDD
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Assessment of antidepressant response
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Haplotype analysis
Number of subjects: 536
Study: 17551299

Group type: EXPERIMENTAL
Intervention: Involved-field irradiation (IFI)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Elective nodal irradiation (ENI)
Number of subjects: 200
Study: 15451222

Group type: EXPERIMENTAL
Intervention: IVIG 1 g/kg per month
Number of subjects: 318

Group type: COMPARATOR
Intervention: Placebo (albumin 0.1%)
Number of subjects: 318
Study: 11435719

Group type: EXPERIMENTAL
Intervention: Lansoprazole (+PPI)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Standard liquid test meal (-PPI)
Number of subjects: 6
Study: 9886730

Group type: EXPERIMENTAL
Intervention: Exercise training group (daily exercise training for 3 months)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-training group (no exercise training)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both training and non-training groups after percutaneous balloon mitral valvuloplasty
Number of subjects: 30
Study: 8022186

Group type: EXPERIMENTAL
Intervention: Rehabilitation
Number of subjects: 347

Group type: COMPARATOR
Intervention: Control
Number of subjects: 347
Study: 2591384

Group type: EXPERIMENTAL
Intervention: iopentol 0.3 g I/kg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: iopentol 0.6 g I/kg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: iopentol 1.2 g I/kg
Number of subjects: 24

Group type: COMPARATOR
Intervention: saline (control)
Number of subjects: 24
Study: 778307

Group type: EXPERIMENTAL
Intervention: Ribavirin (200 mg, three times daily)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Amantadine (100 mg, twice daily)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo (three times daily)
Number of subjects: 29
Study: 30060080

Group type: EXPERIMENTAL
Intervention: Total Laparoscopic Hysterectomy (TLH) for women with BMI < 35 kg/m2
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Total Laparoscopic Hysterectomy (TLH) for women with BMI ≥ 35 kg/m2
Number of subjects: 404
Study: 26566148

Group type: EXPERIMENTAL
Intervention: Atorvastatin + Amiodarone
Number of subjects: 105

Group type: COMPARATOR
Intervention: Amiodarone (Control)
Number of subjects: 105
Study: 26341218

Group type: EXPERIMENTAL
Intervention: SUPER algorithm for early administration of analgesic drugs
Number of subjects: 442

Group type: COMPARATOR
Intervention: Normal process of access to pain-control drugs (Group A)
Number of subjects: 442
Study: 23451769

Group type: EXPERIMENTAL
Intervention: Apixaban 2.5 mg twice daily
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Apixaban 5 mg twice daily
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Apixaban 10 mg twice daily
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Apixaban 25 mg twice daily
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Apixaban 10 mg once daily
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Apixaban 25 mg once daily
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 48
Study: 22184801

Group type: EXPERIMENTAL
Intervention: Micronutrient combination (vitamins C and D3, folic acid, and selenium)
Number of subjects: 192
Study: 18663516

Group type: EXPERIMENTAL
Intervention: 10 U BoNTA
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: 20 U BoNTA
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142
Study: 16856894

Group type: EXPERIMENTAL
Intervention: Coronally positioned flap plus acellular dermal matrix (ADM)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Coronally positioned flap alone
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Coronally positioned flap plus ADM
Number of subjects: 13
Study: 14999218

Group type: EXPERIMENTAL
Intervention: Oral terbutaline
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 20578847

Group type: EXPERIMENTAL
Intervention: 3-day per week take-home dosing schedule
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 3-day per week clinic dosing schedule
Number of subjects: 24

Group type: COMPARATOR
Intervention: Daily dosing schedule
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 3-day per week supervised dosing
Number of subjects: 24
Study: 9252908

Group type: EXPERIMENTAL
Intervention: Cisapride, 0.2 mg/kg three times daily
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 8296578

Group type: EXPERIMENTAL
Intervention: Tricyclic antidepressants (imipramine, clomipramine, desipramine)
Number of subjects: 106
Study: 3520319

Group type: EXPERIMENTAL
Intervention: Intravenous ampicillin during labor
Number of subjects: 160
Study: 31808596

Group type: EXPERIMENTAL
Intervention: Healthy donor FMT
Number of subjects: 35

Group type: COMPARATOR
Intervention: Autologous FMT
Number of subjects: 35
Study: 29802215

Group type: EXPERIMENTAL
Intervention: Aspirin prophylaxis
Number of subjects: 1020

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1020
Study: 28369278

Group type: EXPERIMENTAL
Intervention: CMV viruria (detected by qualitative PCR)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Maternal gonorrhea
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Higher maternal HIV log10 viral load
Number of subjects: 260
Study: 25753932

Group type: EXPERIMENTAL
Intervention: Telephone-delivered cognitive behavioral treatment (CBT) for high anxiety sensitivity, delivered over eight weeks.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 80
Study: 24184053

Group type: EXPERIMENTAL
Intervention: PST (periosteal stimulation therapy) once a week for 10 weeks followed by PST boosters for 6 months
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: PST for 10 weeks followed by control PST boosters for 6 months
Number of subjects: 190

Group type: COMPARATOR
Intervention: Control PST (periosteal needles and brief electrical stimulation of control points) once a week for 10 weeks
Number of subjects: 190
Study: 21409601

Group type: EXPERIMENTAL
Intervention: Antecolic reconstruction of gastro/duodenojejunostomy
Number of subjects: 72

Group type: COMPARATOR
Intervention: Retrocolic reconstruction of gastro/duodenojejunostomy
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Both groups (antecolic and retrocolic)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Patients with DGE
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Patients without DGE
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 72
Study: 18787510

Group type: EXPERIMENTAL
Intervention: IV PTX 500 mg bolus followed by IV infusion of PTX 700 mg for two hours
Number of subjects: 32

Group type: COMPARATOR
Intervention: Normal saline as placebo
Number of subjects: 32
Study: 16532160

Group type: EXPERIMENTAL
Intervention: Diagnostic score for appendicitis applied by emergency room nurses
Number of subjects: 0

Group type: COMPARATOR
Intervention: No intervention (control group of patients not operated for appendicitis)
Number of subjects: 0
Study: 15192991

Group type: EXPERIMENTAL
Intervention: ROI measurement in physical therapy clinical program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implementation of performance measurement model
Number of subjects: 0
Study: 11265909

Group type: EXPERIMENTAL
Intervention: Interactive fever education program
Number of subjects: 87

Group type: COMPARATOR
Intervention: Standard written fever pamphlet
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Both interventions (interactive and written)
Number of subjects: 87
Study: 9284714

Group type: EXPERIMENTAL
Intervention: SRIH infusion (90‐min iv infusion of SRIH at a rate of 9 micrograms/kg.h)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Saline infusion (90‐min iv infusion of isovolumetric amounts of 0.9% saline)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: SRIH infusion
Number of subjects: 29
Study: 8361246

Group type: EXPERIMENTAL
Intervention: Adult Day Health Care (ADHC) provided directly by the VA
Number of subjects: 989

Group type: COMPARATOR
Intervention: Customary care
Number of subjects: 989

Group type: EXPERIMENTAL
Intervention: Contract ADHC programs
Number of subjects: 989
Study: 3532693

Group type: EXPERIMENTAL
Intervention: Fractionated diazoxide administered intravenously (n = 28)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Dihydralazine administered intramuscularly (n = 24)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both drug regimens (diazoxide and dihydralazine)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Furosemide administered intravenously (40 mg)
Number of subjects: 64
Study: 29441952

Group type: EXPERIMENTAL
Intervention: O/V ointment with 2% silver fir bark extract
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 27646425

Group type: COMPARATOR
Intervention: Baseline CRP levels ≤ 3.0mg/L
Number of subjects: 4038

Group type: EXPERIMENTAL
Intervention: Moderately/markedly elevated CRP levels (≥6.9mg/L; 24% of patients)
Number of subjects: 4038
Study: 24676963

Group type: EXPERIMENTAL
Intervention: Maintenance cognitive stimulation therapy (CST) weekly group programme for 24 weeks
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Maintenance cognitive stimulation therapy (CST) weekly group programme for 24 weeks (subgroup taking AChEIs)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 236
Study: 22627378

Group type: EXPERIMENTAL
Intervention: Ductal Injection (DI) with Serva collagenase
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ductal Injection (DI) with Liberase MTF
Number of subjects: 10

Group type: COMPARATOR
Intervention: No Ductal Injection (no DI)
Number of subjects: 10
Study: 19915202

Group type: EXPERIMENTAL
Intervention: EPA (1.6 g/day) and DHA (1.2 g/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Mineral oil (2.4 ml/day)
Number of subjects: 30
Study: 18076918

Group type: EXPERIMENTAL
Intervention: Intravesical instillation of epirubicin plus oral administration of Lactobacillus casei preparation (3 gm per day for 1 year)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Intravesical instillation of epirubicin (30 mg/30 ml saline twice during 1 week, plus 6 additional instillations during 3 months)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Both groups (epirubicin and epirubicin plus Lactobacillus casei)
Number of subjects: 207
Study: 11396390

Group type: EXPERIMENTAL
Intervention: Antihypertensive drugs
Number of subjects: 0
Study: 9691402

Group type: EXPERIMENTAL
Intervention: Hemophilia patients
Number of subjects: 326

Group type: COMPARATOR
Intervention: Controls (male blood donors and children)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Hemophilia patients below age 10
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Hemophilia patients below age 5 treated with monoclonally purified concentrate
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Patients who were rarely treated
Number of subjects: 326
Study: 7949790

Group type: EXPERIMENTAL
Intervention: Re-introduction of normal diet after caffeine withdrawal
Number of subjects: 0

Group type: COMPARATOR
Intervention: Caffeine withdrawal
Number of subjects: 0
Study: 3283624

Group type: EXPERIMENTAL
Intervention: MP induction treatment every 6 months
Number of subjects: 320

Group type: COMPARATOR
Intervention: VCMP induction treatment every 6 months
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Maintenance treatment using the induction scheme Q 8 weeks
Number of subjects: 320

Group type: COMPARATOR
Intervention: No further chemotherapy after remission induction
Number of subjects: 320
Study: 30937935

Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate
Number of subjects: 120

Group type: COMPARATOR
Intervention: Dose-adjusted warfarin (INR: 2.0-3.0)
Number of subjects: 120
Study: 28272589

Group type: EXPERIMENTAL
Intervention: Standardized bedside attending rounds (AR) with 5 practices: pre-rounds huddle, bedside rounds, nurse integration, real-time order entry, whiteboard updates
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Usual rounding practices
Number of subjects: 1200
Study: 27252760

Group type: EXPERIMENTAL
Intervention: DFDBA+PRP
Number of subjects: 12

Group type: COMPARATOR
Intervention: DFDBA alone
Number of subjects: 12
Study: 24601137

Group type: EXPERIMENTAL
Intervention: Intensive glycemic protocol (blood glucose between 80‐110mg/dl)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Conventional glycemic protocol (blood glucose between 180‐220mg/dl)
Number of subjects: 46
Study: 21254815

Group type: EXPERIMENTAL
Intervention: Video decision aid
Number of subjects: 76

Group type: COMPARATOR
Intervention: Verbal description
Number of subjects: 76
Study: 19058683

Group type: EXPERIMENTAL
Intervention: Variolink 2/Excite DSC (etch‐and‐rinse)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Clearfil Esthetic Cement/Clearfil Protect Bond (antibacterial and self‐etching)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Multilink/Multilink Primer (self‐etching)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Multilink Sprint (self‐adhesive)
Number of subjects: 48
Study: 16458124

Group type: EXPERIMENTAL
Intervention: Dalbavancin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 0
Study: 12920449

Group type: EXPERIMENTAL
Intervention: Campto
Number of subjects: 0
Study: 11194089

Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg) plus placebo
Number of subjects: 22000

Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg) plus placebo
Number of subjects: 22000

Group type: EXPERIMENTAL
Intervention: Tamoxifen and Raloxifene
Number of subjects: 22000
Study: 9167869

Group type: EXPERIMENTAL
Intervention: Aromatherapy
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Aromatherapy and massage combined
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Massage alone
Number of subjects: 4

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 4
Study: 1493840

Group type: EXPERIMENTAL
Intervention: Zolpidem 5 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24